Fundraising Fox

Xalud Therapeutics, Inc.

Charlottesville, US · Delaware corporation · 1 known investors

Biotech

Founders & leadership

RC
Raymond ChavezExecutive
SC
Stephen CollinsExecutive
LW
Linda WatkinsNamed on SEC filing

Board

PH
Peter HeineckeBoard director
JF
John ForsayethBoard director

Investors · 1

PBM CapitalreportedCharlottesvillevia Paul B. Manning · board

Reported raises · per SEC filings

Form D private placements

$30.5M disclosed across 3 rounds · 2015–2021

▶$18.2MraisedJun 2021 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jayson RiegerDirector
  • Sean StalfortDirector
  • Stephen CollinsExecutive Officer, Director
  • Paul B. ManningDirector
  • Diem NguyenExecutive Officer, Director
Offering amount
$30M
Amount sold
$18.2M
First sale
May 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedMar 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sean StalfortDirector
  • Stephen CollinsExecutive Officer, Director
  • Jayson RiegerDirector
  • Paul B. ManningDirector
Offering amount
$25.1M
Amount sold
$5M
First sale
Mar 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.3MraisedJul 2015 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter HeineckeDirector
  • Linda WatkinsDirector
  • Raymond ChavezExecutive Officer, Director
  • Stephen CollinsExecutive Officer, Director
  • John ForsayethDirector
Offering amount
$7.3M
Amount sold
$7.3M
Minimum investment
$7.3M
Proceeds to insiders
$712.5K
First sale
May 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Xalud Therapeutics, Inc.'s investors?
Xalud Therapeutics, Inc.'s investors include PBM Capital.
How much funding has Xalud Therapeutics, Inc. raised?
Xalud Therapeutics, Inc. has disclosed $30.5M raised across 3 rounds.
Where is Xalud Therapeutics, Inc. headquartered?
Xalud Therapeutics, Inc. is headquartered in Charlottesville, US.